mounjaro tirzepatide injection eli lilly (tirzepatide) for the Treatment of Type 2 Diabetes, USA India Drug Regulator Approves Eli

Right after

Marx N, Husain M, Lehrke M, Verma S, Sattar N (2022) GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes

The next candidate waiting in the wings is retatrutide, an investigational drug from Eli Lilly that many researchers believe could go even further

Lower inflammation from GLP-1s may prevent atrial fibrillation We know that the medications have benefits on glucose metabolism, but they also affect inflammation and fat metabolism, he said

All information below pertains strictly to in-vitro, ex-vivo, and controlled laboratory research and should not be interpreted as guidance for human or animal application